Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active specific immunotherapy in hepatic metastasis

P M Schlag1, J Milleck, W Liebrich

  • 1Division of Surgery, Robert Rössle-Hospital and Tumour Institute, Max-Delbrück Center of Molecular Medicine, Berlin Buch.

Annali Italiani Di Chirurgia
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.

Oncogene·2015
Same author

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.

European journal of cancer (Oxford, England : 1990)·2014
Same author

Contrast features of breast cancer in frequency-domain laser scanning mammography.

Journal of biomedical optics·2012
Same author

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells.

British journal of cancer·2012
Same author

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.

Gene therapy·2011
Same author

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Zeitschrift fur Gastroenterologie·2011

Active specific immunization (ASI) shows promise in activating immune responses against cancer. This review explores ASI

Area of Science:

  • Immunology and Oncology
  • Cancer immunotherapy research

Background:

  • The immune system recognizes malignant tumors but often fails to mount an effective defense.
  • Tumor-directed immune responses involve T-lymphocytes sensitized to tumor-associated antigens (TAA).
  • Understanding lymphocyte differentiation and effector cell stimulation may inhibit metastasis post-surgery.

Purpose of the Study:

  • To survey the current state of Active Specific Immunization (ASI).
  • To outline novel strategies for enhancing ASI effectiveness.
  • To summarize clinical study results of ASI in malignant melanoma and colorectal carcinoma.

Main Methods:

  • Review of existing literature on Active Specific Immunization (ASI).
  • Analysis of newer approaches to improve ASI efficacy.

Related Experiment Videos

  • Summarization of clinical trial data for ASI in specific cancer types.

    • Main Results:

    • Malignant melanoma is highly immunogenic and extensively studied with ASI.
    • Preliminary experiences with ASI in colon carcinoma patients are presented.
    • ASI aims to activate tumor-specific T- or B-lymphocytes for cancer treatment.

    Conclusions:

    • Deeper insights into immune mechanisms could lead to strategies to impede tumor metastasis.
    • ASI represents a viable approach for activating anti-tumor immune responses.
    • Further research into ASI is warranted for malignant melanoma and colorectal carcinoma.